Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Subjects
Clinical trial NCT05851261 · COMPLETED
Trial details
- NCT number
- NCT05851261
- Sponsor
- Zhejiang Palo Alto Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2023-10-24
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.